1. Market Research
  2. > Biotechnology Market Trends
  3. > Biosensors Market by Application (Point of Care, Home Diagnostics, Research Labs, Biodefense, Environmental Monitoring, Food Industry), Product (Wearable, Non-Wearable), Technology (Electrochemical, Piezoelectric, Optical) & Geography - Analysis & Forecas

The biosensor is a device which is used for detecting, recording, and transmitting information related to any physiological changes or the presence of various chemicals or biological materials in the environment. In other words, we can say that it is an analytical device, which converts the biological response into electrical signals. The biosensors technology is now being used for the development of various biosensor applications, such as the medical, healthcare, biodefense, environment monitoring, and food industries.

This report is based on an extensive research study of the biosensors market and aims at identifying the entire market and all its sub-segments through the extensively detailed classifications. The demand for the biosensors is expecting a significant growth and importance among the industry players across various verticals. APAC is projected to be the fastest growing markets due to the high adoption of medical diagnostics and testing devices.
This report is focused on giving a bird’s eye-view of the industry with regard to the biosensors market, with qualitative analysis at each and every aspect of the classification done on the basis of products, technologies, applications, and geographies. The report provides a forecast of the growth of the biosensors market from 2014 to 2020. A complete competitive landscape of the current market is analyzed from the market share analysis and rankings of current key players; all the other details of the key players are discussed in their company profiles. The competitive information provided in this report includes market shares of the leading companies in the biosensors ecosystem, key developments, core strategies deployed by various players, mergers and acquisitions, new product developments, collaborations, and joint ventures of key manufacturers along with their company profiles.

The report also discusses the future of the global market with road-maps, upcoming technologies, markets, and applications with respect to the biosensors market. The key players in this industry include F. Hoffmann-La Roche Ltd. (Switzerland), LifeScan Inc. (U.S.), Bayer Healthcare AG (Germany), Abbott Point-of-Care Inc. (U.S.), Medtronic (U.S.), Siemens Healthcare (Germany), and others.

Table Of Contents

Biosensors Market by Application (Point of Care, Home Diagnostics, Research Labs, Biodefense, Environmental Monitoring, Food Industry), Product (Wearable, Non-Wearable), Technology (Electrochemical, Piezoelectric, Optical) and Geography - Analysis and Forecas
1 INTRODUCTION 16

1.1 OBJECTIVES OF THE STUDY 16
1.2 MARKET DEFINITION 16
1.3 STUDY SCOPE 17
1.3.1 MARKETS COVERED 17
1.3.2 GEOGRAPHIC SCOPE 18
1.3.3 YEARS CONSIDERED FOR THE STUDY 18
1.4 CURRENCY 18
1.5 PACKAGE SIZE 18
1.6 LIMITATIONS 19
1.7 STAKEHOLDERS 19

2 RESEARCH METHODOLOGY 20

2.1 RESEARCH DATA 20
2.1.1 SECONDARY DATA 21
2.1.1.1 Key data from secondary sources 22
2.1.2 PRIMARY DATA 22
2.1.2.1 Key data from primary sources 22
2.1.2.2 Key industry insights 23
2.1.2.3 Breakdown of primaries 23
2.2 FACTOR ANALYSIS 24
2.2.1 INTRODUCTION 24
2.2.2 DEMAND SIDE ANALYSIS 24
2.2.2.1 Growth in the Healthcare Expenditure 24
2.2.2.2 Progression Toward Healthcare Decentralization 26
2.2.2.3 Prevalence of Diabetes Continues to Increase 27
2.2.2.4 Rapid Growth of the Aging Population 27
2.2.2.5 Related Market Analysis: Transducers Market 29
2.2.2.6 Poor Customer Perception 29
2.3 MARKET SIZE ESTIMATION 30
2.3.1 BOTTOM-UP APPROACH 30
2.3.2 TOP-DOWN APPROACH 31
2.4 MARKET BREAKDOWN and DATA TRIANGULATION 32
2.5 RESEARCH ASSUMPTIONS AND LIMITATIONS 33
2.5.1 ASSUMPTIONS 33
2.5.2 LIMITATIONS 34

3 EXECUTIVE SUMMARY 35

4 PREMIUM INSIGHTS 40

4.1 ADOPTION OF BIOSENSORS IN VARIOUS CLINICAL AND NON-CLINICAL APPLICATIONS IS DRIVING THE BIOSENSORS MARKET 40
4.1 POINT-OF-CARE DOMINATED THE OVERALL BIOSENSORS MARKET, 2013 41
4.2 KEY FACTORS BEHIND THE GROWTH OF THE BIOSENSORS MARKET IN APAC- UPGRADE OF THE EXISTING HEALTHCARE SYSTEMS and LARGE POPULATION 42
4.3 TECHNOLOGICAL ADVANCEMENTS and INCREASED HEALTHCARE COST LIKELY TO DRIVE THE BIOSENSORS MARKET IN THE U.S. 43
4.4 NORTH AMERICA EXPECTED TO CONTINUE TO DOMINATE THE MARKET FOR BIOSENSOR APPLICATIONS 44
4.5 BIOSENSORS MARKET: DEVELOPED VS. DEVELOPING NATIONS 45
4.6 WEARABLE BIOSENSORS LIKELY TO IMPACT THE GLOBAL HEALTHCARE INDUSTRY 45

5 MARKET OVERVIEW 46

5.1 INTRODUCTION 47
5.2 EVOLUTION OF THE BIOSENSORS TECHNOLOGY 47
5.3 MARKET SEGMENTATION 48
5.3.1 BIOSENSORS MARKET, BY APPLICATION 48
5.3.2 BIOSENSORS MARKET, BY TECHNOLOGY 49
5.3.3 BIOSENSORS MARKET SEGMENTATION: BY PRODUCT 50
5.3.4 BIOSENSORS MARKET SEGMENTATION: BY GEOGRAPHY 50
5.4 MARKET DYNAMICS 51
5.4.1 DRIVERS 52
5.4.1.1 Emergence of Nanotechnology/Nanobiosensors 52
5.4.1.2 Significant technological advancements over the last few years 53
5.4.1.3 Glucose monitoring in diabetics patients 53
5.4.1.4 Increase in the demand for home based POC devices 53
5.4.2 RESTRAINTS 54
5.4.2.1 Slow rate of commercialization 54
5.4.2.2 High cost involved in the research and development 55
5.4.2.3 Reluctance toward the adoption of new treatment practices 55
5.4.3 OPPORTUNITIES 56
5.4.3.1 Emerging market in the developing countries 56
5.4.3.2 Use of biosensors for non-medical applications, such as- the food industry, environmental monitoring, and biodefense 56
5.4.4 CHALLENGES 57
5.4.4.1 Government regulations—long certification and approval cycles 57
5.4.4.2 Pricing pressure in the point-of-care market 57
5.4.5 BURNING ISSUE 58
5.4.5.1 High cost devices limit the growth of the biosensors market 58

6 INDUSTRY TRENDS 59

6.1 INTRODUCTION 59
6.2 VALUE CHAIN ANALYSIS 59
6.2.1 VALUE CHAIN ANALYSIS: BIOSENSORS 60
6.3 INDUSTRY TRENDS 61
6.4 EMERGING TRENDS 62
6.4.1 OPEN, CONNECTED HEALTHCARE PLATFORMS 62
6.4.2 PERSONALIZED MEDICINE —A MEDICAL MODEL 62
6.4.3 LAB ON A CHIP 62
6.5 BIOSENSORS PLATFORM AND BUSINESS MODEL 63
6.6 PORTER'S FIVE FORCES ANALYSIS 65
6.6.1 THREATS OF NEW ENTRANTS 65
6.6.2 THREATS OF SUBSTITUTES 66
6.6.3 BARGAINING POWER OF SUPPLIERS 67
6.6.4 BARGAINING POWER OF BUYERS 67
6.6.5 INTENSITY OF RIVALRY 68
6.7 PEST ANALYSIS 68
6.7.1 POLITICAL FACTORS 68
6.7.2 ECONOMIC FACTORS 69
6.7.3 SOCIAL FACTORS 69
6.7.4 TECHNOLOGICAL FACTORS 69
6.8 STRATEGIC BENCHMARKING 69
6.8.1 TECHNOLOGY INTEGRATION and PRODUCT ENHANCEMENT 70
6.8.2 ENTRY INTO TUMOR/CANCER TESTING MARKET 71

7 BIOSENSORS MARKET ANALYSIS, BY APPLICATION 72

7.1 INTRODUCTION 73
7.2 POINT-OF-CARE 74
7.2.1 POINT-OF-CARE APPLICATION, BY GEOGRAPHY 76
7.2.2 POINT-OF-CARE APPLICATION, BY PRODUCT 78
7.2.3 GLUCOSE MONITORING 80
7.2.4 CARDIAC MARKERS 81
7.2.5 INFECTIOUS DISEASES TESTING KITS 81
7.2.6 COAGULATION MONITORING KITS 82
7.2.7 PREGNANCY AND FERTILITY TESTING KITS 83
7.2.8 BLOOD GAS AND ELECTROLYTE 84
7.2.9 TUMOR/CANCER MARKERS 85
7.2.10 URINALYSIS TESTING KITS 86
7.2.11 CHOLESTEROL TEST 87
7.2.12 OTHERS 88
7.3 HOME DIAGNOSTICS 89
7.3.1 HOME DIAGNOSTICS APPLICATION, BY GEOGRAPHY 89
7.3.2 HOME DIAGNOSTICS APPLICATION, BY PRODUCT 91
7.4 RESEARCH LABS 93
7.4.1 RESEARCH LAB APPLICATION, BY GEOGRAPHY 93
7.4.2 RESEARCH LAB APPLICATION, BY PRODUCT 95
7.5 BIODEFENSE 97
7.5.1 BIODEFENSE APPLICATION, BY GEOGRAPHY 97
7.5.2 BIODEFENSE APPLICATION, BY PRODUCT 99
7.6 ENVIRONMENTAL MONITORING 101
7.6.1 ENVIRONMENTAL MONITORING APPLICATION, BY GEOGRAPHY 101
7.6.2 ENVIRONMENTAL MONITORING, BY PRODUCT 103
7.7 FOOD INDUSTRY 105

8 BIOSENSORS MARKET ANALYSIS, BY TECHNOLOGY 109

8.1 INTRODUCTION 110
8.1.1 COMPARATIVE ANALYSIS OF BIOSENSING TECHNOLOGIES (BIOTRANSDUCERS) 110
8.2 ELECTROCHEMICAL BIOSENSORS 111
8.2.1 ADVANTAGES OF ELECTROCHEMICAL BIOSENSORS 111
8.2.2 MAJOR COMPANIES 112
8.2.3 CONDUCTOMETRIC BIOSENSORS 113
8.2.4 AMPEROMETRIC BIOSENSORS 113
8.2.5 POTENTIOMETRIC BIOSENSORS 113
8.2.6 OTHERS 113
8.3 PIEZOELECTRIC BIOSENSORS 113
8.4 OPTICAL BIOSENSORS 114
8.5 THERMAL BIOSENSORS 115
8.6 OTHERS 115

9 BIOSENSORS MARKET ANALYSIS, BY PRODUCT 116

9.1 INTRODUCTION 117
9.2 WEARABLE BIOSENSORS 119
9.2.1 WRIST-WEAR 120
9.2.2 EYE-WEAR 121
9.2.3 FOOT-WEAR 121
9.2.4 NECK-WEAR 121
9.2.5 BODY-WEAR 121
9.2.6 OTHERS 121
9.3 NON-WEARABLE BIOSENSORS 122

10 BIOSENSORS MARKET ANALYSIS, BY GEOGRAPHY 123

10.1 INTRODUCTION 124
10.2 NORTH AMERICA 126
10.3 EUROPE 129
10.4 APAC 131
10.5 ROW 134

11 COMPETITIVE LANDSCAPE 135

11.1 OVERVIEW 135
11.2 MARKET SHARE ANALYSIS, BIOSENSORS MARKET 137
11.3 COMPETITIVE SITUATION AND TRENDS 139
11.3.1 NEW PRODUCT LAUNCHES, 2011-2014 140
11.3.2 ACQUISITION 143
11.3.3 PARTNERSHIPS AND AGREEMENTS 144
11.3.4 EXPANSIONS 145
11.3.5 AWARDS AND RECOGNITION 145

12 COMPANY PROFILES 146 (Overview, Products and Services, Financials, Strategy and Development)*

12.1 ABBOTT POINT OF CARE, INC. 147
12.2 ACON LABORATORIES, INC. 151
12.3 BAYER AG 153
12.4 F. HOFFMAN LA-ROCHE LTD. 156
12.5 LIFESCAN, INC. 161
12.6 LIFESENSORS INC. 164
12.7 MEDTRONIC INC. 166
12.8 NOVA BIOMEDICAL CORPORATION 172
12.9 PHARMACO-KINESIS CORPORATION 175
12.10 SIEMENS AG 177
12.11 UNIVERSAL BIOSENSORS 181
*Details on Overview, Products and Services, Financials, Strategy and Development might not be Captured in case of Unlisted Companies.

13 APPENDIX 185

13.1 INSIGHTS OF INDUSTRY EXPERTS 185
13.2 DISCUSSION GUIDE 186
13.3 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE 189
13.4 AVAILABLE CUSTOMIZATIONS 190
13.5 RELATED REPORTS 191

LIST OF TABLES

TABLE 1 INCREASE IN THE DEMAND FOR GLUCOSE MONITORING SYSTEMS, CONTRIBUTING TO THE GROWTH OF THE BIOSENSORS MARKET 54
TABLE 2 THE SLOW RATE OF COMMERCIALIZATION IS HAMPERING THE GROWTH OF THE BIOSENSORS MARKET 55
TABLE 3 USE OF BIOSENSORS FOR NON-MEDICAL APPLICATIONS IS A PROMINENT OPPORTUNITY FOR THE BIOSENSORS MARKET 57
TABLE 4 STRINGENT GOVERNMENT REGULATIONS AND PRICING PRESSURES ARE THE MAJOR CHALLENGES FACED BY THE BIOSENSORS MARKET 58
TABLE 5 GLOBAL BIOSENSOR MARKET SIZE, BY APPLICATION, 2013-2020 ($BILLION) 73
TABLE 6 BIOSENSORS MARKET SIZE, BY POINT-OF-CARE APPLICATION,
2013-2020 ($BILLION) 75
TABLE 7 POC APPLICATIONS IN THE BIOSENSORS MARKET, BY REGION,
2013-2020 ($MILLION) 76
TABLE 8 POC APPLICATIONS IN THE NORTH AMERICAN BIOSENSORS MARKET,
BY COUNTRY, 2013-2020 ($MILLION) 77
TABLE 9 POC APPLICATIONS IN THE EUROPEAN BIOSENSORS MARKET, BY COUNTRY,
2013-2020 ($MILLION) 77
TABLE 10 POC APPLICATIONS IN THE APAC BIOSENSORS MARKET, BY COUNTRY,
2013-2020 ($MILLION) 78
TABLE 11 POC APPLICATIONS IN THE BIOSENSORS MARKET, BY PRODUCT,
2013-2020 ($MILLION) 79
TABLE 12 POC APPLICATIONS IN THE BIOSENSORS MARKET, BY PRODUCT,
2013-2020 ($MILLION) 79
TABLE 13 GLUCOSE MONITORING KITS IN THE BIOSENSORS MARKET, BY REGION,
2013-2020 ($MILLION) 80
TABLE 14 CARDIAC MARKERS IN THE BIOSENSORS MARKET, BY REGION,
2013-2020 ($MILLION) 81
TABLE 15 INFECTIOUS DISEASES TESTING KITS IN THE BIOSENSORS MARKET, BY REGION, 2013-2020 ($MILLION) 81
TABLE 16 COAGULATION MONITORING IN THE BIOSENSORS MARKET, BY REGION,
2013-2020 ($MILLION) 83
TABLE 17 PREGNANCY and FERTILITY TESTING KITS IN THE BIOSENSORS MARKET, BY REGION, 2013-2020 ($MILLION) 83
TABLE 18 BLOOD GAS and ELECTROLYTES IN THE BIOSENSORS MARKET, BY REGION,
2013-2020 ($MILLION) 84
TABLE 19 TUMOR OR CANCER MARKERS IN THE BIOSENSORS MARKET, BY REGION,
2013-2020 ($MILLION) 85
TABLE 20 URINALYSIS TESTING IN THE BIOSENSORS MARKET, BY REGION,
2013-2020 ($BILLION) 86
TABLE 21 CHOLESTEROL TESTING IN THE BIOSENSORS MARKET, BY REGION,
2013-2020 ($MILLION) 87
TABLE 22 OTHER APPLICATIONS IN THE BIOSENSORS MARKET, BY REGION,
2013-2020 ($MILLION) 88
TABLE 23 HOME DIAGNOSTICS IN THE BIOSENSORS MARKET, BY REGION,
2013-2020 ($MILLION) 89
TABLE 24 HOME DIAGNOSTICS IN THE NORTH AMERICAN BIOSENSORS MARKET,
BY COUNTRY, 2013-2020 ($MILLION) 90
TABLE 25 HOME DIAGNOSTICS IN THE EUROPEAN BIOSENSORS MARKET, BY COUNTRY,
2013-2020 ($MILLION) 90
TABLE 26 HOME DIAGNOSTICS IN THE APAC BIOSENSORS MARKET, BY COUNTRY,
2013-2020 ($MILLION) 91
TABLE 27 HOME DIAGNOSTICS IN THE BIOSENSORS MARKET, BY PRODUCT,
2013-2020 ($MILLION) 92
TABLE 28 HOME DIAGNOSTICS IN THE WEARABLE BIOSENSORS MARKET, BY PRODUCT,
2013-2020 ($MILLION) 92
TABLE 29 RESEARCH LABS IN THE BIOSENSORS MARKET, BY REGION,
2013-2020 ($MILLION) 93
TABLE 30 RESEARCH LABS IN THE NORTH AMERICAN BIOSENSORS MARKET, BY COUNTRY, 2013-2020 ($MILLION) 94
TABLE 31 RESEARCH LABS IN THE EUROPEAN BIOSENSORS MARKET, BY COUNTRY,
2013-2020 ($MILLION) 94
TABLE 32 RESEARCH LABS IN THE APAC BIOSENSORS MARKET, BY COUNTRY,
2013-2020 ($MILLION) 95
TABLE 33 RESEARCH LAB IN THE BIOSENSORS MARKET, BY PRODUCT,
2013-2020 ($MILLION) 96
TABLE 34 RESEARCH LAB IN THE WEARABLE BIOSENSORS MARKET, BY PRODUCT,
2013-2020 ($MILLION) 96
TABLE 35 BIODEFENSE IN THE BIOSENSORS MARKET, BY REGION, 2013-2020 ($MILLION) 97
TABLE 36 BIODEFENSE IN THE NORTH AMERICAN BIOSENSORS MARKET, BY COUNTRY,
2013-2020 ($MILLION) 98
TABLE 37 BIODEFENSE IN THE EUROPEAN BIOSENSORS MARKET, BY COUNTRY,
2013-2020 ($MILLION) 98
TABLE 38 BIODEFENSE IN THE APAC BIOSENSORS MARKET, BY COUNTRY,
2013-2020 ($MILLION) 99
TABLE 39 BIODEFENSE APPLICATIONS IN THE BIOSENSORS MARKET, BY PRODUCT,
2013-2020 ($MILLION) 100
TABLE 40 BIODEFENSE APPLICATIONS IN THE WEARABLE BIOSENSORS MARKET,
BY PRODUCT, 2013-2020 ($MILLION) 100
TABLE 41 ENVIRONMENTAL MONITORING IN THE BIOSENSORS MARKET, BY REGION,
2013-2020 ($MILLION) 101
TABLE 42 ENVIRONMENTAL MONITORING IN THE NORTH AMERICAN BIOSENSORS MARKET,
BY COUNTRY, 2013-2020 ($MILLION) 102
TABLE 43 ENVIRONMENTAL MONITORING IN THE EUROPEAN BIOSENSORS MARKET,
BY COUNTRY, 2013-2020 ($MILLION) 102
TABLE 44 ENVIRONMENTAL MONITORING IN THE APAC BIOSENSORS MARKET, BY COUNTRY, 2013-2020 ($MILLION) 103
TABLE 45 ENVIRONMENTAL MONITORING APPLICATIONS IN THE BIOSENSORS MARKET,
BY PRODUCT, 2013-2020 ($MILLION) 104
TABLE 46 ENVIRONMENTAL MONITORING APPLICATIONS IN THE WEARABLE BIOSENSORS MARKET, BY PRODUCT, 2013-2020 ($MILLION) 104
TABLE 47 ENZYME BIOSENSOR FOR DETECTING FOOD COMPONENTS 105
TABLE 48 FOOD INDUSTRY IN THE BIOSENSORS MARKET, BY REGION,
2013-2020 ($MILLION) 106
TABLE 49 FOOD INDUSTRY IN THE NORTH AMERICAN BIOSENSORS MARKET, BY COUNTRY, 2013-2020 ($MILLION) 107
TABLE 50 FOOD INDUSTRY IN THE EUROPEAN BIOSENSORS MARKET, BY COUNTRY,
2013-2020 ($BILLION) 107
TABLE 51 FOOD INDUSTRY IN THE APAC BIOSENSORS MARKET, BY COUNTRY,
2013-2020 ($MILLION) 108
TABLE 52 COMPARATIVE ANALYSIS BIOTRANSDUCERS USED IN BIOSENSORS 110
TABLE 53 GLOBAL BIOSENSORS MARKET, BY TECHNOLOGY, 2013-2020 ($BILLION) 111
TABLE 54 COMMERCIAL SELF-MONITORING BLOOD GLUCOSE SYSTEMS BASED ON ELECTROCHEMICAL BIOSENSORS 112
TABLE 55 OPTICAL BIOSENSORS MARKET, BY TECHNOLOGY, 2013-2020 ($BILLION) 114
TABLE 56 GLOBAL BIOSENSORS MARKET, BY PRODUCT, 2013-2020 ($BILLION) 117
TABLE 57 WEARABLE BIOSENSORS MARKET, BY PRODUCT, 2013-2020 ($BILLION) 118
TABLE 58 WEARABLE BIOSENSORS MARKET, BY APPLICATION, 2013-2020 ($BILLION) 119
TABLE 59 WRIST-WEAR WEARABLE BIOSENSORS MARKET, BY APPLICATION,
2013-2020 ($BILLION) 120
TABLE 60 NON-WEARABLE BIOSENSORS MARKET, BY APPLICATION, 2013-2020 ($BILLION) 122
TABLE 61 BIOSENSORS MARKET, BY REGION, 2013-2020 ($BILLION) 125
TABLE 62 NORTH AMERICA: BIOSENSORS MARKET, BY COUNTRY, 2013-2020 ($MILLION) 127
TABLE 63 NORTH AMERICA: BIOSENSOR MARKET, BY APPLICATION, 2013-2020 ($MILLION) 128
TABLE 64 EUROPE: BIOSENSORS MARKET, BY COUNTRY, 2013-2020 ($MILLION) 130
TABLE 65 EUROPE: BIOSENSOR MARKET, BY APPLICATION, 2013-2020 ($MILLION) 130
TABLE 66 APAC: BIOSENSORS MARKET, BY COUNTRY, 2013-2020 ($MILLION) 132
TABLE 67 APAC: BIOSENSOR MARKET, BY APPLICATION, 2013-2020 ($MILLION) 133
TABLE 68 ROW: BIOSENSOR MARKET, BY APPLICATION, 2013-2020 ($MILLION) 134
TABLE 69 NEW PRODUCT LAUNCHES, 2011-2014 140
TABLE 70 ACQUISITIONS, 2012-2014 143
TABLE 71 PARTNERSHIPS AND AGREEMENTS, 2011-2014 144
TABLE 72 EXPANSIONS, 2011-2014 145
TABLE 73 AWARDS AND RECOGNITIONS, 2011-2014 145

LIST OF FIGURES

FIGURE 1 MARKETS COVERED 17
FIGURE 2 RESEARCH DESIGN 21
FIGURE 3 HEALTHCARE EXPENDITURE ACROSS VARIOUS PROMINENT COUNTRIES IN THE BIOSENSORS MARKET, 2011 25
FIGURE 4 DECENTRALIZATION ACROSS VARIOUS PROMINENT COUNTRIES IN THE BIOSENSORS MARKET, 2011 26
FIGURE 5 PREVALENCE OF TYPE 1 DIABETES, BY AGE GROUP, 2013 27
FIGURE 6 INCREASE IN THE AGING POPULATION, BY COUNTRY (2005 VS. 2010) 28
FIGURE 7 GLOBAL TRANSDUCERS MARKET ANALYSIS AND ESTIMATION : GEOGRAPHIC SPLIT (2013 VS 2015) 29
FIGURE 8 BOTTOM-UP APPROACH 30
FIGURE 9 TOP-DOWN APPROACH 31
FIGURE 10 MARKET BREAKDOWN and DATA TRIANGULATION 32
FIGURE 11 ASSUMPTIONS OF THE RESEARCH STUDY 33
FIGURE 12 LIMITATIONS OF THE RESEARCH STUDY 34
FIGURE 13 ROADMAP FOR BIOSENSORS 36
FIGURE 14 POC HOLDS THE PROMINENT SHARE AMONG ALL THE BIOSENSORS APPLICATIONS 37
FIGURE 15 NORTH AMERICA HOLDS THE LIONS SHARE IN THE GLOBAL BIOSENSORS MARKET 38
FIGURE 16 RISING DEMAND FOR POC DIAGNOSTICS DEVICES LIKELY TO CONTRIBUTE TO THE GROWTH OF BIOSENSORS MARKET 40
FIGURE 17 POINT OF CARE: LARGEST MARKET FOR BIOSENSORS, DRIVEN BY THE GLUCOSE MONITORING APPLICATION 41
FIGURE 18 JAPAN CAPTURED THE MAXIMUM SHARE IN THE BIOSENSORS MARKET
IN APAC, 2013 42
FIGURE 19 U.S. COMMANDED THE MAXIMUM SHARE OF THE BIOSENSORS MARKET , 2013 43
FIGURE 20 NORTH AMERICA EXPECTED TO WITNESS THE HIGHEST USAGE OF BIOSENSOR TECHNOLOGY, (2013) 44
FIGURE 21 DEVELOPING MARKETS TO GROW FASTER THAN THE DEVELOPED ONES 45
FIGURE 22 WEARABLE BIOSENSORS: KEY GROWTH DRIVER FOR THE POINT- OF- CARE MARKET 45
FIGURE 23 ROAD MAP FOR THE BIOSENSORS TECHNOLOGY 47
FIGURE 24 BIOSENSORS MARKET SEGMENTATION: BY APPLICATION 48
FIGURE 25 BIOSENSORS MARKET SEGMENTATION: BY TECHNOLOGY 49
FIGURE 26 BIOSENSORS MARKET SEGMENTATION: BY PRODUCT 50
FIGURE 27 BIOSENSORS MARKET SEGMENTATION: BY GEOGRAPHY 50
FIGURE 28 THE GROWING DEMAND FOR GLUCOSE MONITORING IN DIABETIC PATIENTS WILL PROPEL THE DEMAND FOR BIOSENSORS 51
FIGURE 29 THE BIOMEDICAL APPLICATIONS OF THE NANOBIOSENSORS 52
FIGURE 30 VALUE CHAIN ANALYSIS (2013): MAJOR VALUE IS ADDED DURING THE RandD AND TESTING PHASES 60
FIGURE 31 MINIATURIZATION IS THE LEADING TREND IN THE CURRENT BIOSENSORS MARKET 61
FIGURE 32 BIOSENSOR PLATFORM AND BUSINESS MODEL 64
FIGURE 33 PORTER'S FIVE FORCES ANALYSIS 65
FIGURE 34 STRATEGIC BENCHMARKING: ROCHE AND BD DIAGNOSTICS LARGELY ADOPTED THE INORGANIC GROWTH STRATEGIES FOR TECHNOLOGY INTEGRATION AND PRODUCT ENHANCEMENT 70
FIGURE 35 STRATEGIC BENCHMARKING: ROCHE LEADS THE TUMOR/CANCER TESTING MARKET 71
FIGURE 36 POINT-OF-CARE DIAGNOSTICS 74
FIGURE 37 POC APPLICATION TO WITNESS THE HIGHEST GROWTH IN APAC 76
FIGURE 38 WEARABLE BIOSENSORS TO REGISTER A PROMINENT GROWTH IN THE POC APPLICATION 78
FIGURE 39 NORTH AMERICA HOLDS A PROMINENT SHARE IN THE GLUCOSE MONITORING BIOSENSORS MARKET 80
FIGURE 40 EUROPE TO BE ONE OF THE IMPORTANT MARKETS FOR THE COAGULATION MONITORING BIOSENSORS 82
FIGURE 41 NORTH AMERICA HOLDS THE LARGEST SHARE FOR THE CANCER MARKERS 85
FIGURE 42 INCREASE IN THE OBESITY DISEASES WILL DRIVE THE DEMAND FOR THE CHOLESTEROL TESTING KITS 87
FIGURE 43 NORTH AMERICA HOLDS THE LARGEST SHARE FOR THE HOME DIAGNOSTIC APPLICATION 89
FIGURE 44 WEARABLE BIOSENSORS HOLD A GREAT DEMAND IN THE HOME DIAGNOSTICS APPLICATIONS 91
FIGURE 45 RESEARCH LAB APPLICATIONS TO WITNESS A PROMINENT GROWTH IN APAC 93
FIGURE 46 WEARABLE BIOSENSORS HOLD THE MAJOR SHARE IN THE RESEARCH LAB APPLICATIONS 95
FIGURE 47 BIODEFENSE APPLICATION TO REGISTER A SIGNIFICANT GROWTH IN APAC 97
FIGURE 48 WEARABLE BIOSENSORS ARE EXPECTED TO WITNESS A PROMINENT GROWTH IN THE BIODEFENSE APPLICATION 99
FIGURE 49 ENVIRONMENT MONITORING APPLICATION TO WITNESS A PROMINENT GROWTH
IN ROW 101
FIGURE 50 WEARABLE BIOSENSORS DOMINATE THE ENVIRONMENTAL MONITORING APPLICATION SEGMENT 103
FIGURE 51 APAC TO WITNESS A PROMINENT GROWTH FOR THE BIOSENSORS MARKET IN THE FOOD INDUSTRY 106
FIGURE 52 TYPES OF ELECTROCHEMICAL BIOSENSORS 112
FIGURE 53 WEARABLE BIOSENSORS HOLD THE MAJOR SHARE IN THE BIOSENSORS MARKET 117
FIGURE 54 APAC TO GROW AT HIGHEST CAGR FOR GLOBAL BIOSENSORS MARKET 124
FIGURE 55 APAC- AN ATTRACTIVE DESTINATION FOR ALL BIOSENSOR APPLICATIONS 125
FIGURE 56 NORTH AMERICA MARKET SNAPSHOT 127
FIGURE 57 EUROPE: BIOSENSORS MARKET, BY COUNTRY, 2013-2020 ($ MILLION) 129
FIGURE 58 APAC MARKET SNAPSHOT 131
FIGURE 59 CHINA TO WITNESS PROMINENT GROWTH IN APAC 132
FIGURE 60 COMPANIES ADOPTED NEW PRODUCT LAUNCHES AS THE KEY GROWTH STRATEGY OVER THE LAST THREE YEARS 135
FIGURE 61 ABBOTT: GREW AT THE HIGHEST CAGR BETWEEN 2009 AND 2013 136
FIGURE 62 GLOBAL BIOSENSORS MARKET SHARE, BY KEY PLAYER, 2013 137
FIGURE 63 MARKET EVOLUTION FRAMEWORK 139
FIGURE 64 COMPETITION FOR MARKET SHARE: ACQUISITION WAS THE KEY STRATEGY 140
FIGURE 65 GEOGRAPHIC REVENUE MIX 146
FIGURE 66 ABBOTT LABORATORIES, INC.: COMPANY SNAPSHOT 147
FIGURE 67 ABOTT POINT-OF-CARE, INC.: SWOT ANALYSIS 149
FIGURE 68 BAYER AG: COMPANY SNAPSHOT 153
FIGURE 69 F. HOFFMAN LA-ROCHE LTD.: COMPANY SNAPSHOT 156
FIGURE 70 F. HOFFMANN-LA ROCHE LTD.: SWOT 159
FIGURE 71 JOHNSON and JOHNSON: COMPANY SNAPSHOT 161
FIGURE 72 MEDTRONIC, INC.: COMPANY SNAPSHOT 166
FIGURE 73 MEDTRONIC, INC.: SWOT 170
FIGURE 74 SIEMENS AG: COMPANY SNAPSHOT 177
FIGURE 75 SIEMENS AG: SWOT 179
FIGURE 76 UNIVERSAL BIOSENSORS: COMPANY SNAPSHOT 181
FIGURE 77 UNIVERSAL BIOSENSORS: SWOT 183

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Global and Chinese Biosensor Industry, 2016 Market Research Report

Global and Chinese Biosensor Industry, 2016 Market Research Report

  • $ 2800
  • Industry report
  • November 2016
  • by Prof Research

The 'Global and Chinese Biosensor Industry, 2011-2021 Market Research Report' is a professional and in-depth study on the current state of the global Biosensor industry with a focus on the Chinese market. ...

Global Automotive Biosensors Market 2016-2020

Global Automotive Biosensors Market 2016-2020

  • $ 2500
  • Industry report
  • September 2016
  • by Infiniti Research Limited

About Biosensor A biosensor consists of a bio-response recognition component. It can be referred to as a bio-component with a transducer that converts a biological response into an electrical signal, which ...

Hepatitis Viruses Diagnostic Tests - Medical Devices Pipeline Assessment, 2016

Hepatitis Viruses Diagnostic Tests - Medical Devices Pipeline Assessment, 2016

  • $ 4000
  • Industry report
  • December 2016
  • by Global Data

Hepatitis Viruses Diagnostic Tests - Medical Devices Pipeline Assessment, 2016 Summary GlobalData's Medical Devices sector report, “Hepatitis Viruses Diagnostic Tests - Medical Devices Pipeline Assessment, ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.